SA Pharmaceutical Journal (SAPJ) official mouthpiece of the Pharmaceutical Society of South Africa (PSSA). SAPJ is aimed at the continuing professional development of the South African pharmacist as a clinical pharmaceutical care practitioner in a community or hospital pharmacy environment or in a regulatory position in the pharmaceutical industry. The journal provides specific clinical reviews on self-medication topics (symptomatic therapy), information on prescription medication (therapy in clinical context) and provides the pharmacists with essential information for referring customers for early medical attention should it be required. Pharmacovigilance – ensuring the safe and appropriate administration and use of medication and reporting of serious adverse events or other adverse drug reactions – is strongly advocated in SAPJ. The SAPJ further supports pharmacists to transform the pharmacy in an accessible, basic primary health care facility for preventing and treating PHC conditions through diagnosis, screening and treatment.

For more information about this journal or to submit an article, please click here.

South Africans at increasing risk of vision loss

With an ever-growing number of South Africans diagnosed with diabetes and an ageing population, loss of vision due to diabetic eye complications and age-related visual conditions is on the rise. Diabetic retinopathy, a complication of diabetes that damages the blood vessels in the retina at the back of the eye, is the leading cause of vision loss globally.

Drones boost healthcare supply chains

Health workers serving remote communities in the Democratic Republic of Congo (DRC) must often undertake a six-day return journey to collect vaccines, traversing dense tropical forests and often the raging Congo River and its tributaries. Drone technology is offering a lifesaving solution to the challenges, including helping to ensure that cold chains are maintained, and vaccine quality is not compromised.

Healthier lifestyles can prevent or delay dementia

More than 50-million people globally live with dementia, a figure expected to treble in the next 30 years, but up to 40% of cases could be prevented or delayed by reducing risks – including getting exercise, eating healthily, and staying mentally fit and socially active.

Rupanase® Allergy Nasal Spray now available in South Africa

New Rupanase® Allergy Nasal Spray reduces symptoms of allergic rhinitis and strengthens cell membranes to fight against a variety of viral infections.

Honour the “brave”: celebrating the next generation of healthcare professionals

Season 2 of ‘Sponsors of Brave’ is now open for nominations – calling all aspiring, current, or recently graduated and community service healthcare students boldly and bravely changing the world around them.

Wildcard SSL